Table 1.

Demographic and clinical characteristics

VariableHealthy ControlCHDNHD
n5109
Age (years), mean +/− SEM35 ± 652 ± 449 ± 5
Gender (male:female)4:17:37:2
Etiology of ESRD (n)NAGlomerular (4)Glomerular (6)
HTN (2)HTN (1)
Type 2 diabetes (2)PCKD (1)
PCKD (1)Reflux nephropathy (1)
Unknown (1)
Diabetes mellitus (%)NA3022
Cardiovascular medications (number of patients)
    angiotensin converting-enzyme inhibitorNA30
    angiotensin II receptor blockerNA20
    α-blockerNA20
    β-blockerNA51
    calcium channel blockerNA81
    diureticNA51
    HMG-CoA reductase inhibitorNA75
  • NA, not applicable; HTN, hypertension; PCKD, polycystic kidney disease; CHD, conventional thrice weekly hemodialysis; NHD, nocturnal hemodialysis; HMG-CoA, 3-hydroxy-3-methyl-glutaryl-CoA.